Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abilify adjunctive to lithium or valproate in bipolar I mania
NCT00257972Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Oct 2004
- Primary completion
- Dec 2007
- Countries
- 17
01
Overview
A Phase 3 trial of aripiprazole in bipolar I disorder, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Oct 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00257972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257972.